Clinical Laserthermia Systems
3,36
SEK
-7,69 %
Mindre end 1K følgere
CLS B
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Finansielt overblik og estimater
Ownership
-7,69%
-10,16%
-8,2%
-18,84%
-43,81%
-80,54%
-97,89%
-98,64%
-98,64%
Clinical Laserthermia Systems is a company active in medical technology. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as malignant melanoma, as well as cancer in the lungs, liver, and pancreas. The company was founded in 2006 and is headquartered in Lund.
Læs mereMarkedsværdi
86,24 mio. SEK
Aktieomsætning
190,1 t SEK
Omsætning
18,78 mio.
EBIT %
-288,87 %
P/E
-
Udbytteafkast, %
-
Finanskalender
16.5
2025
Delårsrapport Q1'25
27.6
2025
Generalforsamling '25
15.8
2025
Delårsrapport Q2'25
ViserAlle indholdstyper
CLS: Clinical Laserthermia Systems AB raises up to SEK 37m through a directed issue for accelerated commercialization and expansion
BioStock: CLS continues toward the goal of becoming cash flow positive by 2026
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools